HeyJaredMedical Industry Feature
Medical Industry Feature highlights topics brought to you by makers of products and services in the medical industry.
- Indexed episodes, last 90 days
- 8
- Latest publication
- Sep 17, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 6, 2026
Latest episodes
Groundbreaking Gene Therapy Restores Natural Hearing for Genetic Deafness (opens the original)
Read excerpt
Guest: Lawrence Lustig, M.D. On this episode of Advances in Care, Erin Welsh speaks with Dr. Lawrence Lustig, otolaryngologist-in-chief at NewYork-Presbyterian and Columbia. Dr. Lustig has spent decades working to advance various interventions to treat genetic deafness and after years of research, his team was the first to show that gene therapies could be effective at reversing hearing loss in mouse models. Dr. Lustig focused his initial study on otoferlin, a gene that is missing in people with
Does Preoperative Anti-VEGF Change Outcomes in Non-Tractional Vitreous Hemorrhage? (opens the original)
Read excerpt
What happens when vitreous hemorrhage (VH) secondary to non-tractional PDR doesn't clear on its own? And does preoperative anti-VEGF actually change surgical outcomes? Maria Berrocal, MD, speaks with Sumit Sharma, MD, about a retrospective case series of 360 patients who underwent vitrectomy for non-clearing VH without tractional elements, examining whether preoperative anti-VEGF injection affects the risk of postoperative rebleeding, when to consider repeat vitrectomy, and how both physicians a
The Positive Impact of Electroconvulsive Therapy for Severe Psychiatric Illness (opens the original)
Read excerpt
Guest: Leonardo Lopez, M.D. On this episode of Advances in Care, Erin Welsh is joined by Dr. Leonardo Lopez, a psychiatrist at NewYork-Presbyterian and vice chair for inpatient services in the Department of Psychiatry at Weill Cornell Medicine. Dr. Lopez and his team are at the forefront of electroconvulsive therapy (ECT) and have built one of the largest programs of its kind in the country dedicated to treating severe psychiatric illness through this revolutionary method. Though it is one of th
The Patient You Might Be Missing: Severe Hypertriglyceridemia in Clinical Practice (opens the original)
Read excerpt
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Erin D. Michos, MD, MHS Severe hypertriglyceridemia (sHTG) affects more than 3 million people, but it often flies under the clinical radar. 1-3 When triglycerides are at or above a 500 mg/dL threshold, it’s no longer just an isolated lab value—it’s a level of hypertriglyceridemia where the clinical implications change, and where a more careful evaluation for underlying causes and risk becomes important. 4 That’s why Dr. Charles Turck sits down with
Secondary IOL Surgery Is Unprofitable Under Current Medicare Reimbursement Rates. Now What? (opens the original)
Read excerpt
Host: Maria Berrocal How much money are retina surgeons losing on secondary IOL procedures? In this episode of Clinical Minute: Retina, host Maria Berrocal, MD, speaks with Nimesh "Nemo" Patel, MD, whose research uncovered how many cases are unprofitable under current Medicare reimbursement rates, and assess how much cash surgeons burn per case. Dr. Patel discusses the implications for patient access, the advocacy efforts underway through the ASRS Health Economics Committee, and why closing the
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.